SPDR S&P Biotech ETF
In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI").
SOURCE: MARKET TAPE & DAILY CREATION/REDEMPTION RECORDS · 1M SHOWN · NET +$351M OVER THIS RANGE
Money keeps arriving — +$351M of net buying over the past month, about 3.1% of the fund's asset base, while the price has returned +36.4% so far this year. At 0.35% a year it is not the cheapest way in — IWM runs the same ground at 0.19%.
COMPOSED FROM THE FUND’S OWN DAILY RECORDS · UPDATED WITH EACH REFRESH
CELL SIZE IS PORTFOLIO WEIGHT · COLOR IS TODAY’S MOVE · TOP 40 POSITIONS
| # | Holding | Weight | Price | Day | 52-wk | |
|---|---|---|---|---|---|---|
| 1 | MRNAMODERNA | 1.41% | $145.13 | +8.9% | ||
| 2 | TWSTTWIST BIOSCIENCE | 1.40% | $145.59 | +6.8% | ||
| 3 | ORKAOruka Therapeutics | 1.37% | $107.96 | +3.0% | ||
| 4 | APGEAPOGEE THERAPEUTICS | 1.48% | $134.75 | +0.0% | ||
| 5 | PRAXPRAXIS PRECISION MEDICINES | 1.29% | $375.94 | +3.1% | ||
| 6 | HALOHALOZYME THERAPEUTICS | 1.03% | $108.17 | +1.9% | ||
| 7 | NTRANATERA | 1.16% | $332.03 | +2.2% | ||
| 8 | KYMRKYMERA THERAPEUTICS | 1.35% | $119.80 | -1.4% | ||
| 9 | PTGXPROTAGONIST THERAPEUTICS | 1.07% | $154.32 | +2.4% | ||
| 10 | DNTHMAGENTA THERAPEUTICS INC | 1.18% | $111.10 | +1.5% | ||
| 11 | CGONCG ONCOLOGY INC | 1.20% | $79.81 | +2.8% | ||
| 12 | RVMDREVOLUTION MEDICINES | 1.20% | $209.46 | -1.1% | ||
| 13 | SYRESPYRE THERAPEUTICS INC | 1.09% | $106.49 | -1.2% | ||
| 14 | TVTXTRAVERE THERAPEUTICS | 1.12% | $65.71 | +1.9% | ||
| 15 | REGNREGENERON PHARMACEUTICALS | 0.96% | $834.04 | +0.9% |
The full book, free with one sign-in.
Top 15 positions are open to everyone. Sign in once and every fund’s complete holdings — plus CSV export, watchlists, and flow alerts — unlock across the network.
Sign in to see all 135| 1 week | +3.9% |
| 1 month | +10.1% |
| 3 months | +25.9% |
| 6 months | +30.8% |
| YTD | +36.4% |
| 1 year | +82.3% |
| 3 years | — |
PRICE RETURN, DISTRIBUTIONS NOT REINVESTED
| 1 week | +$331M |
| 1 month | +$351M |
| 3 months | +$953M |
| YTD | +$655M |
| 1 year | +$1.8B |
CREATION/REDEMPTION DOLLARS, DAILY RECORDS
The top holding is 1.5% of the book; the top ten carry 13%. Spread across 151+ names, it behaves like roughly 110 equally-weighted positions.
VOLATILITY & DRAWDOWN FROM THE DAILY TAPE · CONCENTRATION FROM THE LATEST DISCLOSED BOOK
| Most-traded holdings, options premium | Bullish | Bearish |
|---|---|---|
| MRNA MODERNA | $178M | $164M |
| SLS SELLAS LIFE SCIENCES GROUP | $16M | $10M |
| AMGN AMGEN | $6M | $5M |
| PURR Hyperliquid Strategies | $5M | $4M |
| ABBV ABBVIE | $5M | $5M |
TODAY’S OPTIONS PREMIUM IN THE FUND’S UNDERLYING NAMES